RASIO NEUTROFIL LIMFOSIT DAN RASIO TROMBOSIT LIMFOSIT DENGAN DERAJAT KEPARAHAN PSORIASIS TIPE PLAK
DOI:
https://doi.org/10.33820/mdvi.v50i3.441Keywords:
rasio neutrofil limfosit, rasio trombosit limfosit, psoriasis tipe plak, psoriasis area severity index (PASI)Abstract
Abstrak
Latar Belakang: Psoriasis merupakan gangguan inflamasi sistemik kronis dan rekuren yang mempengaruhi 2-3% populasi. Patogenesis psoriasis melibatkan neutrofil, limfosit, trombosit, sitokin dan kemokin. Penentuan derajat keparahan psoriasis tipe plak yang sering digunakan adalah Psoriasis Area Severity Index (PASI) memiliki kelemahan yaitu subyektivitas antar pemeriksa. Rasio neutrofil limfosit (N/L) dan rasio trombosit limfosit (T/L) adalah penanda sederhana respon inflamasi sistemik yang mudah diukur dan murah sebagai bagian dari pemeriksaan darah rutin dan umum digunakan dalam penyakit inflamasi kronis.
Tujuan: mengetahui perbedaan dan hubungan antara rasio N/L dan rasio T/L dengan derajat keparahan psoriasis tipe plak berdasarkan PASI.
Metode: Penelitian menggunakan rancangan potong lintang dengan subyek telah memenuhi kriteria inklusi dan eksklusi. Analisis komparatif dan korelatif digunakan untuk menilai perbedaan dan hubungan kedua rasio dengan skor PASI.
Hasil: Jumlah subyek penelitian 48 orang dibagi menjadi 3 kelompok psoriasis (derajat ringan, sedang dan berat). Terdapat perbedaan antara rasio N/L dan rasio T/L dengan derajat keparahan psoriasis tipe plak (p<0,05). Terdapat hubungan antara rasio N/L dan rasio T/L dengan derajat keparahan psoriasis tipe plak berdasarkan PASI (p<0,05 dan r: 0,550, r: 0,314).
Kesimpulan: terdapat perbedaan dan hubungan antara rasio N/L dan rasio T/L dengan derajat keparahan psoriasis tipe plak berdasarkan PASI.
Kata Kunci: rasio neutrofil limfosit, rasio trombosit limfosit, psoriasis tipe plak, psoriasis area severity index (PASI)
Downloads
References
1. Polat M, Bugdayci G, Kaya H, Oğuzman H. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis. Acta Dermatovenerologica Alpina, Pannonica Adriat. 2017;26(4):97–100.
2. Krisnarto E, Novitasari A, Aulirahma DM. Faktor Prediktor Kualitas Hidup Pasien Psoriasis : Studi Cross Sectional. J Unimus. 2017;49:43–51.
3. Gudjonsson JE. Fitzpatrick’s Dermatology. 9 ed. Kang S, Amagai M, Bruckner A, Enk A, Margolis D MA, editor. New York: McGraw-Hill Education; 2019. 457–497 hal.
4. Jacobs T, Kgokolo CM. Treatment of psoriasis. SA Pharm J. 2021;88(1):23–6.
5. Paul C, Gourraud PA, Bronsard V, Prey S, Puzenat E, Aractingi S, et al. Evidence-based recommendations to assess psoriasis severity: Systematic literature review and expert opinion of a panel of dermatologists. J Eur Acad Dermatology Venereol. 2010;24(SUPPL. 2):2–9.
6. Akyol M, Alper S, Atakan N, Başkan EB, Gürer MA, Koç E, et al. TÜRKİYE Psori̇asi̇sTedavi̇ Kilavuzu-2016. Türkderm. 2016;50(Suppl 1):2016.
7. Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS One. 2015;10(3):1–14.
8. Wang WM, Wu C, Gao YM, Li F, Yu XL, Jin HZ. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients. BMC Immunol. 2021;22(1):1–7.
9. Dahlan M. Besar sampel dalam penelitian kedokteran dan kesehatan. Seri Evidence Based Medicine 2. 4 ed. Jakarta: Lembaga Epidemiologi Indonesia; 2016.
10. Perdoski. Alur tatalaksana psoriasis vulgaris (tipe plak) di Indonesia. Jakarta: Kelompok Studi Psoriasis Indonesia; 2019.
11. Chiang CC, Cheng WJ, Korinek M, Lin CY, Hwang TL. Neutrophils in Psoriasis. Front Immunol. 2019;10(October).
12. Von Hundelshausen P, Weber C. Platelets as immune cells: Bridging inflammation and cardiovascular disease. Circ Res. 2007;100(1):27–40.
13. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. The inflammatory response in mild and in severe psoriasis. Br J Dermatol. 2004;150(5):917–28.
14. Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis. 2005;64(SUPPL. 2):30–6.
15. Res AD. Lesional elastase activity in psoriasis Diagnostic and prognostic significance. 1995;632–5.
16. Zheng Y. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. 2008;357–67.
17. Kanelleas A, Liapi C, Katoulis A, Stavropoulos P, Avgerinou G, Georgala S. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept. 2011;845–50.
18. Bhat T, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M. Neutrophil to lymphocyte ratio and cardiovascular diseases : a review. 2013;55–9.
19. Paliogiannis P, Satta R, Deligia G, Farina G, Bassu S. Associations between the neutrophil ‑ to ‑ lymphocyte and the platelet ‑ to ‑ lymphocyte ratios and the presence and severity of psoriasis : a systematic review and meta ‑ analysis. Clin Exp Med. 2018;(0123456789).
20. Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T, Sen N. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. 2013;9527:1–5.
21. Zareifar S, Reza M, Far F, Golfeshan F. Changes in Platelet Count and Mean Platelet Volume During Infectious and Inflammatory Disease and Their Correlation With ESR and CRP. 2014;D(July 2013):245–8.
22. Katoh N. Platelets as versatile regulators of cutaneous inflammation. 2009;53:89–95.
23. Ali S, Uc AK, Ugan Y, Yilmaz R. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis : neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. 2015;1–5.
24. Herster F, Karbach S, Chatterjee M, Weber ANR. Platelets : Underestimated Regulators of Autoinflammation in Psoriasis. J Invest Dermatol. 2021;141(6):1395–403.
25. Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K. Neutrophil – lymphocyte ratio , platelet – lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis : Response to therapy with biologics. 2017;i(September 2016):1–10.
